Yıl: 2020 Cilt: 31 Sayı: 5 Sayfa Aralığı: 348 - 355 Metin Dili: İngilizce DOI: 10.5152/tjg.2020.20413 İndeks Tarihi: 19-06-2021

The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists

Öz:
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a novel acute infectious disease that has rapidly reached staggering pandemic proportions. This review addresses gastroenterologists, hepatologists, liver transplant (LT) specialists, and health-care professionals working in the field of liver diseases and liver transplantation. It has been writ ten based on a limited number of publications, recommendations of national and international liver and organ transplantation societies, and experiences of patients with COVID-19 around the world. The purpose of this review is to provide information addressing questions and concerns about COVID-19, to reveal the effects of the novel disease on patients with chronic liver disease and LT recipients, and to share information about ways in which this pandemic will affect clinical practices. We, the Turkish Association for the Study of the Liver (TASL), would like to remind you that this text is actually not a practical guide. It is imperative to act according to the standards set by health-care institutions and the Ministry of Health, Republic of Turkey.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. Cevik M, Bamford C, Ho A. COVID-19 Pandemic-a focused review for clinicians. Clinical Microbiology and Infection 2020 April 21. Doi.org/10.1016/j.cmi.2020.04.023 [Crossref]
  • 2. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. New Engl J Med 2020; 382: 727-33. [Crossref]
  • 3. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054-62. [Crossref]
  • 4. Xiao F, Tang M, Zheung X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology 2020; 158: 1831-3. [Crossref]
  • 5. Fix OK, Hameed B, Fontana RJ, et al. Clinical best practice advice for hepatology and liver transplant providers during the COVID-19 pandemic: AASLD Expert Panel Consensus statement. 2020 April 16. doi:10.1002/HEP.31281. [Crossref]
  • 6. Boettler T, Newsome PN, Mondelli MU, et al. Care of patients with liver disease during COVID-19 pandemic: EASL-ESCMID position paper. JHEP Reports 2020 April. doi: 10.1016/h.jhepr.2020.100113. [Crossref]
  • 7. Feng G, Zheng KI, Yan QQ, et al. COVID-19 and liver dysfunction: Current insights and emergent therapeutic strategies. J Clin Transl Hepatol 2020; 28: 18-24. [Crossref]
  • 8. AASLD - Clinical insights for hepatology and liver transplant providers during the COVID-19 Pandemic. March 23, 2020.
  • 9. Guan W-J, Ni Z-Y, Hu Y, et al. Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med 2020 Feb 28. doi:10.1056/NEJMMoa2002032.
  • 10. Sultan S, Altayar O, Siddique SM, et al. AGA institute rapid review of the GI and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative medicine of patients with COVID-19. Gastroenterology 2020 May. Doi: 10.1053/j.gastro.2020.05.001. [Crossref]
  • 11. Fan Z, Chen L, Li J, et al. Clinical features of COVID-19 related liver damage. MedRvix 2020 Feb 28. doi: 10.1101/2020.02.26.20026071. [Crossref]
  • 12. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020; 8: 420-2. [Crossref]
  • 13. Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19): Groups at higher risk for severe illness. Published February 11, 2020.
  • 14. Ji D, c E, Xu J, et al. Implication of non-alcoholic fatty liver diseases (NAFLD) in patients with COVID-19: A preliminary analysis. J Hepatol 2020 April. doi: 10.1016/jhep.2020.03.044. [Crossref]
  • 15. United Network for Organ Sharing. COVID-19 and solid organ transplant. https://unos.org/covid. 2020 April.
  • 16. American Society of Transplantation. 2019-nCoV (Coronavirus): FAQs for organ donation and transplantation. 2020 March 20.
  • 17. Halazun KJ, Rosenblatt R. Lest we forget. Am J Transplant. 2020 Mar 31. doi:10.1111/ajt.15888. [Crossref]
  • 18. Association of Organ Procurement Organizations. COVID-19 (coronavirus) bulletin. 2020 March 26.
  • 19. D’Antiga L. Coronaviruses and immunosuppressed patients. The fact during the third epidemic. Liver Transpl 2020 March 20. doi:10.1002/lt.25756. [Crossref]
  • 20. Qin J, Wang H, Qin X, et al. Perioperative presentation of COVID-19 disase in liver transplant recipient. Hepatology 2020 March 7. doi: 10.1002/hep.31257. [Crossref]
  • 21. Kissler SM, Tedijanto C, Goldstein E, et al. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science 2020. doi. 10.1126/science.abb5793. [Crossref]
  • 22. Dong L, et al. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther 2020: 14; 58-60. [Crossref]
  • 23. Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for Coronavirus disease 2019 (COVID-19). A review. JAMA April 13.
  • 24. Yao X, Ye F, Zhang M, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020 March 9. Doi:10:1093/cid/ciaa237. [Crossref]
  • 25. Shiraki K, Daikoku T. Favipiravir, an anti-influenza drug against life-threatening RNA virus infections. Pharmacol Ther 2020; 209: 107512. [Crossref]
  • 26. Qingxian C, Yang M, Liu D, et al. Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study. Engineering 2020. doi.org/10.1016/j.eng.2020.03.007.
  • 27. Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 2020 March 18. doi: 10.1056/NEJMMoa2001282.
  • 28. Grein J, Ohmagari N, Shin D, et al. Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med 2020 April 10. doi: 10.1056/NEJMoa2007016. [Crossref]
APA Kabaçam G, DAYANGAC M, Ucbilek E, Ercin C, gunsar f, AKYILDIZ M, akarsu m, Demir M, Kaymakoglu S, KARASU Z, Idilman R (2020). The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists. , 348 - 355. 10.5152/tjg.2020.20413
Chicago Kabaçam Gökhan,DAYANGAC MURAT,Ucbilek Enver,Ercin Cemal Nuri,gunsar fulya,AKYILDIZ MURAT,akarsu mesut,Demir Mehmet,Kaymakoglu Sabahattin,KARASU Zeki,Idilman Ramazan The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists. (2020): 348 - 355. 10.5152/tjg.2020.20413
MLA Kabaçam Gökhan,DAYANGAC MURAT,Ucbilek Enver,Ercin Cemal Nuri,gunsar fulya,AKYILDIZ MURAT,akarsu mesut,Demir Mehmet,Kaymakoglu Sabahattin,KARASU Zeki,Idilman Ramazan The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists. , 2020, ss.348 - 355. 10.5152/tjg.2020.20413
AMA Kabaçam G,DAYANGAC M,Ucbilek E,Ercin C,gunsar f,AKYILDIZ M,akarsu m,Demir M,Kaymakoglu S,KARASU Z,Idilman R The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists. . 2020; 348 - 355. 10.5152/tjg.2020.20413
Vancouver Kabaçam G,DAYANGAC M,Ucbilek E,Ercin C,gunsar f,AKYILDIZ M,akarsu m,Demir M,Kaymakoglu S,KARASU Z,Idilman R The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists. . 2020; 348 - 355. 10.5152/tjg.2020.20413
IEEE Kabaçam G,DAYANGAC M,Ucbilek E,Ercin C,gunsar f,AKYILDIZ M,akarsu m,Demir M,Kaymakoglu S,KARASU Z,Idilman R "The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists." , ss.348 - 355, 2020. 10.5152/tjg.2020.20413
ISNAD Kabaçam, Gökhan vd. "The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists". (2020), 348-355. https://doi.org/10.5152/tjg.2020.20413
APA Kabaçam G, DAYANGAC M, Ucbilek E, Ercin C, gunsar f, AKYILDIZ M, akarsu m, Demir M, Kaymakoglu S, KARASU Z, Idilman R (2020). The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists. Turkish Journal of Gastroenterology, 31(5), 348 - 355. 10.5152/tjg.2020.20413
Chicago Kabaçam Gökhan,DAYANGAC MURAT,Ucbilek Enver,Ercin Cemal Nuri,gunsar fulya,AKYILDIZ MURAT,akarsu mesut,Demir Mehmet,Kaymakoglu Sabahattin,KARASU Zeki,Idilman Ramazan The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists. Turkish Journal of Gastroenterology 31, no.5 (2020): 348 - 355. 10.5152/tjg.2020.20413
MLA Kabaçam Gökhan,DAYANGAC MURAT,Ucbilek Enver,Ercin Cemal Nuri,gunsar fulya,AKYILDIZ MURAT,akarsu mesut,Demir Mehmet,Kaymakoglu Sabahattin,KARASU Zeki,Idilman Ramazan The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists. Turkish Journal of Gastroenterology, vol.31, no.5, 2020, ss.348 - 355. 10.5152/tjg.2020.20413
AMA Kabaçam G,DAYANGAC M,Ucbilek E,Ercin C,gunsar f,AKYILDIZ M,akarsu m,Demir M,Kaymakoglu S,KARASU Z,Idilman R The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists. Turkish Journal of Gastroenterology. 2020; 31(5): 348 - 355. 10.5152/tjg.2020.20413
Vancouver Kabaçam G,DAYANGAC M,Ucbilek E,Ercin C,gunsar f,AKYILDIZ M,akarsu m,Demir M,Kaymakoglu S,KARASU Z,Idilman R The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists. Turkish Journal of Gastroenterology. 2020; 31(5): 348 - 355. 10.5152/tjg.2020.20413
IEEE Kabaçam G,DAYANGAC M,Ucbilek E,Ercin C,gunsar f,AKYILDIZ M,akarsu m,Demir M,Kaymakoglu S,KARASU Z,Idilman R "The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists." Turkish Journal of Gastroenterology, 31, ss.348 - 355, 2020. 10.5152/tjg.2020.20413
ISNAD Kabaçam, Gökhan vd. "The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists". Turkish Journal of Gastroenterology 31/5 (2020), 348-355. https://doi.org/10.5152/tjg.2020.20413